Fig. 5
From: Establishing and validating a new metabolic marker-driven prognosis signature for cutaneous melanoma
Comparative analysis of the tumor immune microenvironment in high- versus low-risk groups. (A) Exploring of the association between risk scores and various immune cell types. (B) Analysis of the link between immune cell prevalence and six genes within the prognostic model. (C) Examination of the relationship between risk score and immune-related score. (D) TCGA pathology sections showing higher tumor immune cell infiltrations in low-risk patients compared with those in high-risk patients (*p < 0.05; **p < 0.01; and ***p < 0.001).
